A detailed history of Sawgrass Asset Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Sawgrass Asset Management LLC holds 97,357 shares of ABT stock, worth $11.4 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares
97,357
Previous 100,933 3.54%
Holding current value
$11.4 Million
Previous $10.5 Million 5.84%
% of portfolio
1.16%
Previous 1.14%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$100.07 - $118.13 $357,850 - $422,432
-3,576 Reduced 3.54%
97,357 $11.1 Million
Q2 2024

Jul 18, 2024

BUY
$100.73 - $112.44 $37,169 - $41,490
369 Added 0.37%
100,933 $10.5 Million
Q1 2024

May 13, 2024

SELL
$109.52 - $120.96 $444,870 - $491,339
-4,062 Reduced 3.88%
100,564 $11.4 Million
Q4 2023

Feb 06, 2024

BUY
$90.19 - $110.4 $3 Million - $3.68 Million
33,316 Added 46.72%
104,626 $11.5 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $238,060 - $285,633
-2,492 Reduced 3.38%
71,310 $6.91 Million
Q2 2023

Jul 13, 2023

SELL
$100.78 - $112.29 $305,262 - $340,126
-3,029 Reduced 3.94%
73,802 $8.05 Million
Q1 2023

May 09, 2023

BUY
$96.86 - $114.01 $6.48 Million - $7.62 Million
66,854 Added 670.08%
76,831 $7.78 Million
Q3 2022

Nov 09, 2022

SELL
$96.76 - $112.03 $15,481 - $17,924
-160 Reduced 1.58%
9,977 $965,000
Q2 2022

Aug 04, 2022

SELL
$102.07 - $123.37 $101,457 - $122,629
-994 Reduced 8.93%
10,137 $1.1 Million
Q1 2022

May 18, 2022

BUY
$114.02 - $139.04 $1.27 Million - $1.55 Million
11,131 New
11,131 $1.32 Million
Q4 2021

Feb 03, 2022

SELL
$115.53 - $141.46 $1.36 Million - $1.66 Million
-11,750 Closed
0 $0
Q3 2021

Nov 04, 2021

SELL
$116.66 - $129.06 $880,316 - $973,886
-7,546 Reduced 39.11%
11,750 $1.39 Million
Q2 2021

Aug 05, 2021

SELL
$105.79 - $124.53 $9.84 Million - $11.6 Million
-93,013 Reduced 82.82%
19,296 $2.24 Million
Q1 2021

Apr 29, 2021

SELL
$108.84 - $128.23 $2.21 Million - $2.61 Million
-20,338 Reduced 15.33%
112,309 $13.5 Million
Q4 2020

Jan 22, 2021

SELL
$105.0 - $114.42 $354,690 - $386,510
-3,378 Reduced 2.48%
132,647 $14.5 Million
Q3 2020

Nov 02, 2020

SELL
$91.64 - $111.29 $1.87 Million - $2.28 Million
-20,457 Reduced 13.07%
136,025 $14.8 Million
Q2 2020

Jul 27, 2020

BUY
$76.57 - $98.0 $616,388 - $788,900
8,050 Added 5.42%
156,482 $14.3 Million
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $7.44 Million - $10.9 Million
-118,426 Reduced 44.38%
148,432 $11.7 Million
Q4 2019

Feb 10, 2020

SELL
$78.51 - $87.4 $1.62 Million - $1.8 Million
-20,643 Reduced 7.18%
266,858 $23.2 Million
Q3 2019

Oct 30, 2019

SELL
$81.84 - $88.74 $20.9 Million - $22.7 Million
-255,258 Reduced 47.03%
287,501 $24.1 Million
Q2 2019

Jul 23, 2019

SELL
$72.88 - $85.0 $591,785 - $690,200
-8,120 Reduced 1.47%
542,759 $45.6 Million
Q1 2019

May 07, 2019

SELL
$66.22 - $80.06 $653,392 - $789,952
-9,867 Reduced 1.76%
550,879 $44 Million
Q4 2018

Feb 01, 2019

BUY
$65.56 - $74.27 $2.4 Million - $2.72 Million
36,629 Added 6.99%
560,746 $40.6 Million
Q3 2018

Nov 19, 2018

BUY
$60.81 - $73.36 $29.2 Million - $35.2 Million
479,455 Added 1073.52%
524,117 $38.4 Million
Q2 2018

Jul 26, 2018

SELL
$57.57 - $63.54 $23 Million - $25.4 Million
-400,000 Reduced 89.96%
44,662 $27.1 Million
Q2 2018

Jul 26, 2018

BUY
$57.57 - $63.54 $8.94 Million - $9.87 Million
155,363 Added 53.7%
444,662 $27.1 Million
Q1 2018

May 15, 2018

SELL
$56.27 - $63.62 $792,562 - $896,087
-14,085 Reduced 4.64%
289,299 $17.3 Million
Q4 2017

Feb 12, 2018

SELL
$53.68 - $57.47 $94,476 - $101,147
-1,760 Reduced 0.58%
303,384 $17.3 Million
Q3 2017

Nov 09, 2017

SELL
$48.06 - $53.64 $2.19 Million - $2.45 Million
-45,610 Reduced 13.0%
305,144 $16.3 Million
Q2 2017

Aug 11, 2017

BUY
N/A
350,754
350,754 $17.1 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sawgrass Asset Management LLC Portfolio

Follow Sawgrass Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawgrass Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawgrass Asset Management LLC with notifications on news.